Optimal Contemporary Management of Hypertrophic Cardiomyopathy: The Importance of Early Diagnosis and Targeted Therapy
Hypertrophic Cardiomyopathy: New Evidence, Updated Guidelines to Support Optimal Management
Differentiating S1P-Based Therapeutics for the Treatment of Patients with Multiple Sclerosis
VTE and Anticoagulation – Guideline Updates for 2024
Review of New and Emerging Therapies that Improve Tolerability and Adherence in Patients with Relapsing Multiple Sclerosis
Brain Penetrant BTK Update: Reducing Neuroinflammation to Optimize Outcomes for Patients with Multiple Sclerosis
Clinical Update on Anti-CD20 Therapeutics for Patients with Relapsing Multiple Sclerosis
Update on Advanced Anti-CD20 Therapeutics to Improve Outcomes for Patients with Multiple Sclerosis
Shared Decision-Making and Patient Education to Promote Adherence to DOACs and Continuity of Care in VTE
Strategies to Coordinate the Multidisciplinary Team for Secondary Prevention, Long-Term Treatment, and the Assessment of Bleeding Risk
